tiprankstipranks
Trending News
More News >
Annovis Bio Inc (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Financial Statements

Compare
721 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently $80.57M. The company's EPS TTM is $-0.37; its P/E ratio is -1.89; Annovis Bio is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -26.69M$ -45.03M$ -25.51M$ -14.54M$ -6.64M
EBITDA$ -26.69M$ -45.03M$ -25.51M$ -14.50M$ 0.00
Net Income$ -24.59M$ -56.20M$ -25.33M$ -14.49M$ -5.46M
Balance Sheet
Cash & Short-Term Investments$ 10.55M$ 5.75M$ 28.38M$ 45.69M$ 8.07M
Total Assets$ 13.93M$ 10.21M$ 36.02M$ 46.00M$ 8.12M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -10.55M$ -5.75M$ -28.38M$ -45.69M$ -8.07M
Total Liabilities$ 4.62M$ 17.96M$ 7.70M$ 1.51M$ 578.38K
Stockholders' Equity$ 9.31M$ -7.75M$ 28.32M$ 44.49M$ 7.54M
Cash Flow
Free Cash Flow$ -21.89B$ -39.97M$ -17.31M$ -9.13M$ -3.97M
Operating Cash Flow$ -21.89B$ -39.97M$ -17.31M$ -9.13M$ -3.97M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 26.69B$ 17.34M$ 4.61K$ 46.74M$ 12.04M
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS